Assessment of Parkinson’s disease medication state through automatic speech analysis

Pompili, Anna; Solera-Urena, Rubén; Abad, Alberto; Cardoso, Rita; Guimarães, Isabel; Fabbri, Margherita; Martins, Isabel; Ferreira, Joaquim

http://hdl.handle.net/10400.26/39946

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Assessment_of_Parkinsons_Disease_Medication_State.pdf		239.08 KB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

Parkinson’s disease (PD) is a progressive degenerative disorder of the central nervous system characterized by motor and nonmotor symptoms. As the disease progresses, patients alternate periods in which motor symptoms are mitigated due to medication intake (ON state) and periods with motor complications (OFF state). The time that patients spend in the OFF condition is currently the main parameter employed to assess pharmacological interventions and to evaluate the efficacy of different active principles. In this work, we present a system that combines automatic speech processing and deep learning techniques to classify the medication state of PD patients by leveraging personal speech-based bio-markers. We devise a speakerdependent approach and investigate the relevance of different acoustic-prosodic feature sets. Results show an accuracy of 90.54% in a test task with mixed speech and an accuracy of 95.27% in a semi-spontaneous speech task. Overall, the experimental assessment shows the potentials of this approach towards the development of reliable, remote daily monitoring and scheduling of medication intake of PD patients.